A case of a 6-year-old girl with anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis

Clin Exp Nephrol. 2011 Aug;15(4):596-601. doi: 10.1007/s10157-011-0423-3. Epub 2011 Mar 1.

Abstract

A 6-year-old girl was admitted to our hospital with proteinuria, hematuria, skin rash and joint pain of the lower limbs. Due to rapid progression of renal insufficiency, hemodialysis and peritoneal dialysis were performed. She was diagnosed with rapidly progressive glomerulonephritis. Kidney biopsy showed severe crescent formation (50% of glomeruli) and no deposition of any immunoglobulins or complements. Serologically, anti-neutrophil cytoplasmic autoantibody (ANCA) was negative not only by ELISA against proteinase-3 and myeloperoxidase-ANCA but also by indirect immunofluorescent assay against cytoplasmic and perinuclear ANCA. Anti-glomerular basement membrane antibody was also negative. In the acute phase, proinflammatory cytokines such as soluble tumor necrosis factor receptor 1 (sTNFR1), soluble interleukin (IL)-2 receptor (sIL2R), IL-6 and chemokine IL-8 were elevated. The patient was diagnosed with ANCA-negative pauci-immune crescentic glomerulonephritis (CrGN). Intensive treatment with methylprednisolone pulse therapy, plasma exchange, and multiple drug therapy including prednisolone and cyclophosphamide resulted in histopathological improvement and complete remission of proteinuria. There was a possibility that sTNFR1, sIL2R, IL-6 and IL-8 might be involved in the initiation and progression of ANCA-negative pauci-immune CrGN, and to remove and suppress these cytokines might be an effective way to treat ANCA-negative pauci-immune CrGN.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Autoantibodies / analysis
  • Child
  • Cyclophosphamide / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Glomerulonephritis / drug therapy
  • Glomerulonephritis / immunology*
  • Humans
  • Methylprednisolone / administration & dosage
  • Plasmapheresis
  • Prednisolone / administration & dosage
  • Proteinuria / drug therapy
  • Proteinuria / etiology
  • Pulse Therapy, Drug

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantibodies
  • antiglomerular basement membrane antibody
  • Cyclophosphamide
  • Prednisolone
  • Methylprednisolone